Intelligence Dashboards

Upcoming FDA target action dates. Know when approval decisions are expected.

Track Phase 1-4 trial activity by company. See who has the strongest clinical pipeline.

Deep dive into any company's trial portfolio by therapeutic area and phase.

See who's competing in each indication. Trial counts, sponsors, and phase breakdown.

Rising and falling indications based on trial activity over time.

Small biotechs with FDA approvals and strong Phase 3 pipelines.

FDA-approved biosimilars, reference products, and market leaders.

Drugs losing exclusivity by year with Medicare spending at risk. Historical data proves what happens.

Find underserved indications with low competitive density.

Competitive density heatmap across all therapeutic areas.

Head-to-head comparison of any two company portfolios.

Browse the indication taxonomy and see coverage metrics.